Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Incyte

Incyte claims FDA priority review for bile duct cancer drug

Incyte claims FDA priority review for bile duct cancer drug Significant need for new therapies in hard-to-treat cancer type. Incyte’s new drug pemigatinib has been given a priority review for a rare type of bile duct cancer by ... Incyte says cholangiocarcinoma affects between 0.3 – 3.4 people per 100, 000 in

CML LIFE

by INCYTE with support from Open Health PBC. CML Life has been developed using evidence-based methodology, including an extensive literature review focusing on engagement, adherence and side effect management. ... CML LIFE - by INCYTE with support from

Life Effects

CML LIFE - by INCYTE with support from Open Health PBC.

Start from Scratch

CML LIFE - by INCYTE with support from Open Health PBC.

Could There Be More?

CML LIFE - by INCYTE with support from Open Health PBC.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...